第一单位：
Sarah Cannon Research Institute, Nashville, TN.
作者：
Ian W,Flinn [1]
;
Peter,Hillmen [2]
;
Marco,Montillo [3]
;
Zsolt,Nagy [4]
;
Árpád,Illés [5]
;
Gabriel,Etienne [6]
;
Julio,Delgado [7]
;
Bryone J,Kuss [8]
;
Constantine S,Tam [9]
;
Zoltán,Gasztonyi [10]
;
Fritz,Offner [11]
;
Scott,Lunin [12]
;
Francesco,Bosch [13]
;
Matthew S,Davids [14]
;
Nicole,Lamanna [15]
;
Ulrich,Jaeger [16]
;
Paolo,Ghia [17]
;
Florence,Cymbalista [18]
;
Craig A,Portell [19]
;
Alan P,Skarbnik [20]
;
Amanda F,Cashen [21]
;
David T,Weaver [22]
;
Virginia M,Kelly [23]
;
Barry,Turnbull [23]
;
Stephan,Stilgenbauer [23]
作者单位：
Sarah Cannon Research Institute, Nashville, TN.
[1]
Tennessee Oncology, Nashville, TN.
[2]
St. James's Institute of Oncology, The Leeds Teaching Hospitals, Leeds, United Kingdom.
[3]
Department of Haematology and Oncology, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy.
[4]
First Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
[5]
Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
[6]
Hematology Department, Institut Bergonie, Bordeaux, France.
[7]
Hospital Clinic, Barcelona, Spain.
[8]
Flinders Medical Centre-Flinders University, Bedford Park, SA, Australia.
[9]
Peter MacCallum Cancer Centre, St. Vincent's Hospital and University of Melbourne, Melbourne, VIC, Australia.
[10]
Department of Internal Medicine and Hematology, Petz Aladár County Hospital, Győr, Hungary.
[11]
Hematology, University Hospital Ghent, Gent, Belgium.
[12]
Florida Cancer Specialists, Venice, FL.
[13]
Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.
[14]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
[15]
New York Presbyterian, Columbia University Medical Center, New York, NY.
[16]
Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
[17]
Universita' Vita-Salute San Raffaele and San Raffaele Scientific Institute, Milan, Italy.
[18]
Laboratoire d'hématologie, Hôpital Avicenne, Paris, France.
[19]
Division of Hematology and Oncology, University of Virginia, Charlottesville, VA.
[20]
John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ.
[21]
Siteman Comprehensive Cancer Center, Washington University, St. Louis, MO.
[22]
Verastem Oncology, Needham, MA.
[23]
Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany; and.
[24]
Klinik für Innere Medizin I, Universitätsklinikum des Saarlandes, Homburg, Germany.
[25]
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗体, 单克隆(Antibodies, Monoclonal);染色体缺失(Chromosome Deletion);染色体, 人, 17对(Chromosomes, Human, Pair 17);无病生存(Disease-Free Survival);双盲法(Double-Blind Method);女(雌)性(Female);人类(Humans);异喹啉类(Isoquinolines);白血病, 淋巴细胞, 慢性, B细胞(Leukemia, Lymphocytic, Chronic, B-Cell);男(雄)性(Male);中年人(Middle Aged);嘌呤类(Purines);复发(Recurrence);Smith-Magenis综合征(Smith-Magenis Syndrome);存活率(Survival Rate);肿瘤抑制蛋白质p53(Tumor Suppressor Protein p53)
DOI
10.1182/blood-2018-05-850461
PMID
30287523
发布时间
2021-02-02
换一批
换一批
